Expression levels and clinical-pathological correlations of HER2/neu in primary and metastatic human breast cancer

Annals of the New York Academy of Sciences

Volumn 1028, Issue , 2004, Pages 463-472

  Stefano, Rosalba ^a,c   Agostara, Biagio ^b   Calabrò, Maurizio ^b   Campisi, Ildegarda ^b   Ravazzolo, Barbara ^b   Traina, Adele ^b   Miele, Monica ^a   Castagnetta, Luigi ^a,b  

^a UNIVERSITY OF PALERMO   (Italy)

^b ARNAS Civico   (Italy)

^c Experimental Oncology Unit   (Italy)

Author keywords

Breast cancer; HER2 neu immunohistochemistry; Oncogene

Indexed keywords

ESTROGEN; PROGESTERONE RECEPTOR;

ADULT; AGED; BREAST CANCER; BREAST METASTASIS; CANCER RELAPSE; CLINICAL FEATURE; CONFERENCE PAPER; CORRELATION ANALYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MENOPAUSE; ONCOGENE NEU; RETROSPECTIVE STUDY; SCORING SYSTEM; TUMOR VOLUME;

EID: 14944378076     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1322.055     Document Type: Conference Paper

References (28)

1. STERN, D.F., P.A. HEFFERNAN & R.A. WEINBERG. 1986. A product of the neu protooncogene is a receptorlike protein associated with tyrosine kinase activity. Mol. Cell. Biol. 6(5): 1729-1740.
2. HYNES, N.E. & D.F. STERN. 1994. The biology of erbB-2/neu/HER2 and its role in cancer. Bioch. Biophys. Acta 1198: 165-184.
3. AKIYAMA T., C. SUDO, H. OGAWARA, et al. 1986. The product of human c-erbB-2 gene: a 185 kilodalton glycoprotein with tyrosine kinase activity. Science 232: 1644-1646.
4. BARGMANN, C.I., M.C. HUNG & R.A. WEINBERG. 1986. The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature 319: 226-230.
5. COUSSENS, L., T.L. YANG-FENG, Y.-C. LIAO, et al. 1985. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230: 1132-1139.
6. SCHECHTER A.L., D.F. STERN, L. VAIDYANATHAN, et al. 1984. The neu oncogene: an erbB-related gene encoding a 185,000-Mr tumor antigen. Nature 213: 513-516.
7. RIESE, D. J. & D. F. STERN. 1998. Specificity within the EGF family/ErbB receptor family signaling network. Bioessays 20(1): 41-48.
8. MAGUIRE, H.C. & M.I. GREENE. 1989. The neu (c-erbB-2) oncogene. Semin. Oncol. 16: 148-155
9. VAN DER GEER, P., T. HUNTER & R.A. LINDBERG. 1994. Receptor protein tyrosine kinases and their signal transduction pathways. Annu. Rev. Cell. Biol. 10: 251-337.
10. PINKAS-KRAMARSKI, R., R. EILAM, I. ALROY, et al. 1997. Differential expression of NDF/neuregulin receptors ErbB-3 and ErbB-4 and involvement in inhibition of neuronal differentiation. Oncogene 15(23): 2803-2815.
11. KLAPPER, L. N., S. GLATHE, N. VAISMAN et al. 1999. The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors. Proc. Natl. Acad. Sci. USA 96(9): 4995-5000.
12. PINKAS-KRAMARSKI, R., M. SHELLY, B.C. GUARINO, et al. 1998. erbB Tyrosine kinases and two neuregulin families constitute a ligand receptor network. Mol. Cell. Biol. 18: 6090-6101.
13. ALROY I. & Y. YARDEN. 1997. The erbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interaction. FEBS Lett. 410: 83-86.
14. TZAHAR E., G. LEVKOWITZ, D. KARUNAGARAN, et al. 1996. A hierarchical network of interreceptor interactions determines sal transduction by neu differentiation factor/neuregulin and epidermal growt factor. Mol. Cell. Biol. 16: 5276-5287.
15. BENZ, C.C., G.K. SCOTT, J.C. SARUP, et al. 1992. Estrogen-dependent, tamoxifen-resistant tumorigenic growt of MCF-7 cells transfected with HER2/neu. Breast Cancer Res. Treat. 24: 85-95.
16. HUDZIAK, R.M., J. SCHLESSINGER & A. ULLRICH. 1987. Increased expression of the putative growt factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells. Proc. Natl. Acad. Sci. USA 84: 7159-7163.
17. DI FIORE, P.P., J.H. PIERCE, M.H. KRAUS et al. 1987. ErbB-2 is a potent oncogen when overexpressed in NIH/3T3 cells. Science 237: 178-182.
18. GUY, C.T., M.A. WEBSTER, M. SCHALLER, et al. 1992. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl. Acad. Sci. USA 89: 10578-10582.
19. MCKENZIE, S.J., P.J. MARKS, T. LAM, et al. 1989. Generation and characterization of monoclonal antibodies specific for the human neu oncogene product, p185. Oncogene 4: 543-548.
20. HANCOCK, M.C., B.C. LANGTON, T. CHAN, et al. 1991. A monoclonal antibody against the c-erbB-2 protein enhances the cytotoxicity of cis- diamminedichloroplatinum against human breast and ovarian tumor cell lines. Cancer Res. 51: 4575-4580.
21. SLAMON, D.J., W. GODOLPHIN, L.A. JONES, et al. 1989. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244(4905): 707-712.
22. SLAMON, D.J., G.M. CLARK, S.G. WONG, et al. 1987. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235(4785): 177-182.
23. WRIGHT, C., B. ANGUS, S. NICHOLSON, et al. 1989. Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer. Cancer Res. 49: 6941-6944.
24. CLARK, G.M. & W.L. MCGUIRE. 1991. Follow-up study of HER2/neu amplification in primary breast cancer. Cancer Res. 51: 944-948.
25. IGLEHART, J.D., M.H. KRAUS, B.C. LANGTON, et al. 1990. Increased erbB-2 gene copies and expression in multiple stages of breast cancer. Cancer Res. 50: 6701-6707.
26. REVILLION, F., J. BONNETERRE & J.P. PEYRAT. 1998. ERBB2 oncogene in human breast cancer and its clinical significance. Eur. J. Cancer 34(6): 791-808.
27. MENARD, S., A. BALSARI, P. CASALINI, et al. 2002. HER-2-positive breast carcinomas as a particular subset with peculiar clinical behaviors. Clin. Cancer Res. 8(2): 520-525.
28. ROSS, J. S., J. A. FLETCHER, G. P. LINETTE, et al. 2003. The Her-2/neu gene and protein in breast cancer: biomarker and target of therapy. Oncologist 8(4): 307-325.